rs121909308
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000178.4(GSS):c.799C>T(p.Arg267Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000171 in 1,461,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
GSS
NM_000178.4 missense
NM_000178.4 missense
Scores
13
5
1
Clinical Significance
Conservation
PhyloP100: 3.13
Genes affected
GSS (HGNC:4624): (glutathione synthetase) Glutathione is important for a variety of biological functions, including protection of cells from oxidative damage by free radicals, detoxification of xenobiotics, and membrane transport. The protein encoded by this gene functions as a homodimer to catalyze the second step of glutathione biosynthesis, which is the ATP-dependent conversion of gamma-L-glutamyl-L-cysteine to glutathione. Defects in this gene are a cause of glutathione synthetase deficiency. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
PP5
Variant 20-34935611-G-A is Pathogenic according to our data. Variant chr20-34935611-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 8527.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSS | NM_000178.4 | c.799C>T | p.Arg267Trp | missense_variant | 9/13 | ENST00000651619.1 | NP_000169.1 | |
GSS | NM_001322494.1 | c.799C>T | p.Arg267Trp | missense_variant | 9/13 | NP_001309423.1 | ||
GSS | NM_001322495.1 | c.799C>T | p.Arg267Trp | missense_variant | 9/13 | NP_001309424.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSS | ENST00000651619.1 | c.799C>T | p.Arg267Trp | missense_variant | 9/13 | NM_000178.4 | ENSP00000498303.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251450Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135888
GnomAD3 exomes
AF:
AC:
3
AN:
251450
Hom.:
AF XY:
AC XY:
1
AN XY:
135888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461128Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 726922
GnomAD4 exome
AF:
AC:
25
AN:
1461128
Hom.:
Cov.:
30
AF XY:
AC XY:
18
AN XY:
726922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glutathione synthetase deficiency with 5-oxoprolinuria Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 18, 2024 | Variant summary: GSS c.799C>T (p.Arg267Trp) results in a non-conservative amino acid change located in the glutathione synthase, substrate-binding domain (IPR004887) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251450 control chromosomes. c.799C>T has been reported in the literature in the compound heterozygous state in individuals affected with Glutathione Synthetase Deficiency (e.g. Shi_1996, Dahl_1997). These data indicate that the variant may be associated with disease. In vitro studies in e.coli report that this variant results in absent GSS activity (e.g. Shi_1996) and kinetic impairment of enzyme function (e.g.Njalsson_2000). The following publications have been ascertained in the context of this evaluation (PMID: 9215686, 10861239, 8896573). ClinVar contains an entry for this variant (Variation ID: 8527). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1996 | - - |
Inherited glutathione synthetase deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2023 | Experimental studies have shown that this missense change affects GSS function (PMID: 8896573, 10861239, 30581542). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GSS protein function. ClinVar contains an entry for this variant (Variation ID: 8527). This missense change has been observed in individual(s) with glutathione synthetase deficiency (PMID: 8896573, 11445798). This variant is present in population databases (rs121909308, gnomAD 0.003%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 267 of the GSS protein (p.Arg267Trp). This variant disrupts the p.Arg267 amino acid residue in GSS. Other variant(s) that disrupt this residue have been observed in individuals with GSS-related conditions (PMID: 31198081), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
.;D;.;D;D;.
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;H;.;H;H;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;.;.;.;D
REVEL
Pathogenic
Sift
Uncertain
.;D;.;.;.;D
Sift4G
Pathogenic
.;D;.;.;.;D
Polyphen
1.0
.;D;.;D;D;.
Vest4
0.94, 0.96
MutPred
0.97
.;Loss of catalytic residue at R267 (P = 0.0741);Loss of catalytic residue at R267 (P = 0.0741);Loss of catalytic residue at R267 (P = 0.0741);Loss of catalytic residue at R267 (P = 0.0741);.;
MVP
0.99
MPC
0.82
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at